摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Deuteriohex-2-enoic acid

中文名称
——
中文别名
——
英文名称
3-Deuteriohex-2-enoic acid
英文别名
3-deuteriohex-2-enoic acid
3-Deuteriohex-2-enoic acid化学式
CAS
——
化学式
C6H10O2
mdl
——
分子量
115.15
InChiKey
NIONDZDPPYHYKY-QYKNYGDISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    8
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • Deuterated hepatitis C protease inhibitors
    申请人:Perni B. Robert
    公开号:US20070225297A1
    公开(公告)日:2007-09-27
    A deuterated α-ketoamido steric specific compound of the formula wherein D denotes a deuterium atom on a steric specific carbon atom.
    一种代的α-酮基立体特异化合物,其化学式为其中D表示立体特异碳原子上的一个原子。
  • Process for preparing optically enriched compounds
    申请人:Vertex Pharmceuticals Incorporated
    公开号:EP2194039A1
    公开(公告)日:2010-06-09
    This invention relates to a process for preparing a compound of Formula 1 wherein: the carbon atoms alpha and beta to the carboxy group are stereocenters; R1 is independently H, optionally substituted aliphatic, optionally substituted cycloaliphatic, optionally substituted arylaliphatic, optionally substituted heteroaliphatic or optionally substituted heteroarylaliphatic; R'1 is deuterium such that the deuterium enrichment is at least 50%; R'2 is -NHR2 or -OE; R2 is H, optionally substituted aliphatic, optionally substituted cycloaliphatic, optionally substituted arylaliphatic, optionally substituted heteroaliphatic or optionally substituted heteroarylaliphatic; and E is C1-6 alkyl or benzyl; wherein the process comprises the steps of: a) forming a salt of a compound of Formula 1, and b) crystallizing said salt to give a compound of greater than 55% enantiomeric excess.
    本发明涉及一种制备式 1 化合物的工艺 其中 羧基的碳原子α和β是立体中心; R1 独立地为 H、任选取代的脂肪族、任选取代的环脂族、任选取代的芳脂族、任选取代的杂脂族或任选取代的杂芳脂族; R'1 是富集度至少为 50%; R'2 是-NHR2 或-OE; R2 是 H、任选取代的脂肪族、任选取代的环脂族、任选取代的芳脂族、任选取代的杂脂族或任选取代的杂芳脂族;以及 E 是 C1-6 烷基或苄基; 其中该工艺包括以下步骤 a) 形成式 1 化合物的盐,和 b) 结晶所述盐,得到对映体过量率大于 55%的化合物。
  • DEUTERATED HEPATITIS C PROTEASE INHIBITORS
    申请人:Vertex Pharmceuticals Incorporated
    公开号:EP1993994A2
    公开(公告)日:2008-11-26
  • COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE
    申请人:Flagship Pioneering Innovations V, Inc.
    公开号:US20210289794A1
    公开(公告)日:2021-09-23
    The invention comprises methods for decreasing colonization by a bacterium of a gut of a stink bug, the method comprising providing a composition comprising vanillin or an analog thereof; and delivering said composition to an egg from which the stink bug will hatch, whereby colonization by the bacterium within the gut of the stink bug hatched from the egg treated with the composition is decreased relative to a stink bug hatched from an untreated egg. In some embodiments, the decrease in colonization by the bacterium decreases the fitness of the stink bug, e.g., decreases reproductive ability, survival, rate of development, number of eggs, number of hatched eggs, adult emergence rate, body length, body width, body mass, or cuticle thickness. In some embodiments of the methods herein, the bacterial colonization-disrupting agent is an inhibitor of bacterial metabolism. In some embodiments, the bacterial colonization-disrupting agent is a polyhydroxyalkanoate (PHA) synthesis inhibitor.
  • US8247532B2
    申请人:——
    公开号:US8247532B2
    公开(公告)日:2012-08-21
查看更多